Table of Contents: AIDS Treatment News - 1996
Published by John S. James

Table Of Contents

AIDS Treatment News 261: December 20
Marijuana and Research; Medical Marijuana: Legal Issues for Physicians, Others; Vaccine Report Available; Geneva AIDS Conference Seeks Community Planning Coordinator; National Conference on Women and HIV -- Late Breaker Deadline March 21; Call for Research on Better Use of Existing Drugs in Advanced Disease; 1592: Consensus Letter on Access to New Glaxo Drug; d4T+AZT -- Unexpected CD4 Drop Seen in Study; Viral Load Seminars in January and February, Eight U.S. Cities
AIDS Treatment News 260: December 6
Buyers' Clubs List, December 1996; Books: IMPURE SCIENCE: AIDS, ACTIVISM, AND THE POLITICS OF KNOWLEDGE, by Steven Epstein, University of California Press, 1996; Albendazole Free from Buyers' Club; FDA Advisory Committee Deadlocks on Delavirdine; Fewer AIDS Deaths: San Francisco Information; Buyers' Club Crisis -- Challenge for AIDS Community
AIDS Treatment News 259: November 20
Qigong Program on San Francisco KQED TV, Beginning December 7; Retroviruses Conference: Press Deadline December 6; AZT Twice-Daily Tablets Approved; Dosing Concerns; FDA Internet Regulation? Public Comment Accepted until December 16; Medical Marijuana Wins in California and Arizona; The New Antiretroviral Arsenal; 1592: Two Studies Recruiting; Federal Team Developing Treatment Principles for HIV Infection; Birmingham UK Drug Therapy Conference -- Early Report
AIDS Treatment News 258: November 6
Bioethics: Major Meetings in San Francisco, November 20-25; Hepatitis C: Protease Structure of Virus Published; AIDSACT, New Email List for Activists; TREATMENT ISSUES Article on New Therapies After Protease Inhibitors; Starting and Changing HIV Treatment: Conference Call Nov. 5, Recording Later; Retroviruses Conference -- Some Scholarships Available; International Treatment Access and Research, How You Can Help -- Interview with Dr. Peter Piot of UNAIDS; NTZ for Cryptosporidiosis: Larger Expanded Access; Buyers' Club/FDA Conflict; IL-2: Controlled Trial Finds Major CD4 Increases; HCG: New Kind of KS Treatment?
AIDS Treatment News 257: October 16
Benefits Planning: What You Must Know (Part II); PhRMA Drops Lawsuit on Government Drug Pricing; Viral Load Seminars for Physicians -- Rescheduled; Viral Load Access Consensus Statement; Large Combination Trials with AZT, ddI, ddC: Results Published; Marijuana and Chocolate; Medical Marijuana: The State of the Research
AIDS Treatment News 256: October 2
Viral Load Seminars for Physicians: Late October Dates in U.S. Cities; Viral Load Overview from Treatment Action Group; CMV Information: Print, Online, Phone, Video; 3TC Clinical Benefit: More Data Presented; Congress, Late Sept. 1996: Funding, ADAP, Immigration; Pharmaceutical Industry Sues to Stop Discount Pricing to Clinics; Ritonavir and Saquinavir Combination: 12-Week Data at ICAAC; CKR-5: New Study Confirms Some Do Not Get HIV; Grassroots Organizing by Internet: An Example; SPECIAL NOTICE
AIDS Treatment News 255: September 18
Errata: Issues 253, 254; Benefits Planning -- What You Must Know: Interview with Daniel Fortuno, AIDS Benefits Counselors; Washington AIDS Events: Major Demonstrations October 11, 12, and 13; ICAAC Conference AIDS Overview -- Available by Toll-Free Phone Call; Nelfinavir (Viracept(TM)) Expanded Access Announced; Retroviruses Conference Sets January 22-26 1997 Meeting Dates: Abstract Deadline October 16
AIDS Treatment News 254: September 4
AIDS TREATMENT NEWS Associates (ATNA) Receives Nonprofit Status; Register to Vote: Time Running Out; HIV Sensitivity Testing: Organizing for Access; CKR-5 -- Understanding the News; Ritonavir Plus Saquinavir: Two Trials With Different Results; ddI plus d4T; Human Growth Hormone Approved for Wasting
AIDS Treatment News 253: August 21
Calendar of AIDS Research and Treatment Meetings, Late 1996 and Beyond; Medical Marijuana: California Update; 1592 -- New Experimental Antiretroviral; Five-Drug or Six-Drug Antiretroviral Therapy -- Conversation with Steven Scheibel, M.D.; Nelfinavir Protease Inhibitor Study Recruiting
AIDS Treatment News 252: August 7
San Francisco Cannabis Buyers' Club Raided Aug. 4; DHEA: Modest Viral Load Reduction in Patients; San Francisco Area: "Highlights from Vancouver" at Kaiser Oakland, August 20; Reminder: Free Viral Load Testing From Roche, Only Until August 16; ADAP Treatment-Access Emergency -- Interview with William Arnold, ADAP Working Group; 3TC: Combination Trial Stopped Early As Clinical Benefit Shown; Editorial: Time to End the Death Trials
AIDS Treatment News 251: July 17
Other Vancouver News; After Vancouver: Documenting Improved Survival; Expert Panel's New Recommendations for Antiviral Treatment; New View of Antiretroviral Treatment: Illustrations from "Late Breaker" Abstracts; Vancouver in Perspective
AIDS Treatment News 250: July 10
World Wide Web: AIDS Treatment News Publishes Over 100 Sites; Neuropathy: Nutrient Therapies; West Hollywood: AIDS and Chinese Medicine Conference, July 25-28; Delavirdine Expanded Access Program Information on World Wide Web; CMV RETINITIS AND TREATMENT CME Course on World Wide Web; SCIENCE Publishes Major AIDS Issue June 28; Full Text on Web; Vancouver Conference: Each Day Summarized Nightly on World Wide Web; Nevirapine Approved; NAC: First Controlled Trial, Positive Results; Cryptosporidiosis: NTZ at Buyers' Club; Customs Holds Second Shipment
AIDS Treatment News 249: June 19
AIDS and Alternative Medicine: A Journalist's Perspective; Needlestick Exposure: CDC Recommends Three-Drug Regimen; Free Viral Load Tests: Remember to Dial 1 Before 888; Nevirapine Recommended for Approval; Azithromycin Approved for Once-Weekly MAC Prophylaxis; Internet Free Speech Wins Court Test; New Optimism on Controlling HIV Infection
AIDS Treatment News 248: June 5
Access for All": Communication Strategy Proposal for Activists at International Conference; Activist Communications, Activities at Vancouver Conference; AIDS TREATMENT NEWS New Index Available; Prison: California Conference on HIV and Prison Issues, Oakland, June 27; 3TC: Glaxo Wellcome Broadens Patient Assistance; PMPA: New Information; Op Ed: Viral Load FDA Approval Delays; Viral Load: New Proof of Importance for Disease Staging and Prognosis; Viral Load: New Recommendations for Clinical Practice; Viral Load Approved; Free Test Offered to All in U.S. with HIV
AIDS Treatment News 247: May 15
AIDS TREATMENT NEWS Policy on Pharmaceutical-Company Revenue; Pharmaceutical Contributions and AIDS Organizations: Request for Input; AIDS and Media in Developing Countries: Request for Information; Computer Communication in Developing Countries: Request for Information; Best Internet, Computer Sites on AIDS: Request for Information; AIDS TREATMENT NEWS Back Issues on Web; Workshop on Traditional Healing and Policy, June 13 Near Washington, D.C.; World Medicine and Western Medicine: The Missing Dialog -- Interview, Kaiya Montaocean, Co- Director, Center for Natural and Traditional Medicines; NIH Scientists Find Cofactor for HIV Entry
AIDS Treatment News 246: May 1
Vancouver Conference Satellite Meetings, Part II; Paris Conference on NAC, Similar Therapeutic Approaches, May 21-23; AIDSWatch 1996: National Lobbying Days in Washington, May 19-21; Federal Policy: Ryan White, OAR, Testing Newborns; Alternative Treatments for HIV: Nationwide Survey Seeks Users; Women and HIV: Conference Calls May 14, 15, on Treatment Concerns; California: 3TC Now Available through ADAP; Crixivan(R) Price: Behind the Reduction; Kaposi's Sarcoma: DaunoXome(R) Approved; Improved HIV Survival Indicates Effect of Therapy; Saquinavir: Combination Shows Survival Benefit; New Formulation Trial Recruiting
AIDS Treatment News 245: April 17
Vancouver Conference: Make Travel Plans Now. Focus, Program, and Satellite Meetings; FDA Reform in Congress: FDA's Concerns; FDA Reform in Congress: Interview with Peter Barton Hutt; rGP-160 Treatment Vaccine (VaxSyn): Canadian Study Finds No Benefit; Chinese Medicine: Qigong Exercise Tape Available; Sinusitis: Helpful Background, Treatment Article; Delavirdine Available on Expanded Access; Protease Inhibitors: Background Information; Protease Inhibitors: Ritonavir and Saquinavir Combination Trial Recruiting -- Seven U.S., Canada Sites Including San Francisco; Crixivan(R) Price Break for Cash Customers: $97 Per Month Less, If You Ask
AIDS Treatment News 244: April 3
AIDS Medications Needed Abroad; California: AB 2812 Would Outlaw Anonymous Testing; San Francisco Protest Against Meeting Disruptions; California: Clinical Trials Computer Service Now Available Statewide; Cidofovir Recommended for Approval for CMV Retinitis; AZT, ddI, and ddC Combinations at FDA Advisory Hearing; Viral Load: Inconclusive FDA Hearing; AIDS Research at NIH: Study Panel Issues Major Report; Indinavir (Crixivan(R)) Access and Distribution; Protease Inhibitors: Patient Education Critical; San Francisco: 3TC Available Now to Residents through ADAP Program
AIDS Treatment News 243: March 20
AIDS and Alternative Medicine, Seattle, April 28; Consensus Statement on the Further Development of Protease Inhibitors And Human Growth Hormone; Human Growth Hormone Not Recommended for Approval on Narrow Advisory Panel Vote; FDA Antiviral Hearings: Community Perspectives; Protease Inhibitors at FDA Advisory Hearings; Ritonavir (NORVIR(TM)), Abbott Protease Inhibitor, Approved; Indinavir (Crixivan(R)), Merck Protease Inhibitor, Approved
AIDS Treatment News 242: March 6
DHEA: Threat to Access?; Retroviruses Conference: Obtaining Abstracts Agouron's Results; Protease Inhibitors at Retroviruses Conference: Agouron's Results; Study Finds AIDS Patients Live Longer When Their Doctors Have More Experience Treating HIV; Rolipram: Antidepressant Used in Europe and Japan Might Have Promise Against TNF, HIV; Protease Inhibitor Approvals: Will People Be Cut Off Drug? Followup Studies Proposal Needs Support; Curcumin: Clinical Trial Finds No Antiviral Effect
AIDS Treatment News 241: February 20
Press Gag Rules at AIDS Conference; AB 9: California Bill Would End County Mandate for Last-Resort Care, Including Communicable Diseases; Growing Crisis in Paying for Care; d4T Plus ddI Antiviral Results; Merck Protease Inhibitor: More News from Retroviruses Conference
AIDS Treatment News 240: February 6
Computer Censorship Law, ACLU Test Case, Begin February 8; NMAC Skills Building Conference in South Africa: Facilitators Wanted; Prisoners: Send Address Updates; Contacting Organizations; FDA Antiviral Advisory Committee Meetings; Vancouver International Conference: Community Booths Deadline Extended; Agouron Starts Phase III Protease Inhibitor Studies; Ritonavir (Abbott Protease Inhibitor) Proves Survival Benefit in Late-Stage AIDS; Protease Inhibitors in Human Testing: Annotated List; Protease Inhibitors at Retroviruses Conference
AIDS Treatment News 239: January 23
DHEA Clinical Experience: Interview with Jon Kaiser, M.D.; DHEA and AIDS; Retroviruses Conference Notes; Needle Exchange: Experts Deplore Shalala Remarks; Ritonavir: Expanded Access Begins, Warning on Drug Interactions; Protease Inhibitor Update: Treatment Combination Strategies; Viral Load: New Confirmation from Major Delavirdine Studies; NTZ: Cryptosporidiosis New Treatment
AIDS Treatment News 238: January 3
Computer Censorship Update; San Francisco: Cryptosporidiosis Water Warning; Opportunistic Infection Prevention: National Video Symposium, January 11; AZT plus 3TC Combination Results Published; CD8 Cells: Suppressive Factors Discovered; Getting Your Insurer to Cover New HIV Treatments: A Crash Course

Copyright / How to reach AIDS Treatment News
ÆGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990,2000. ÆGiS & the Sisters of Saint Elizabeth of Hungary. All materials appearing on ÆGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of ÆGIS and the Sisters of Saint. Elizabeth of Hungary, or the party credited as the provider of the content. Please contact the party credited as the provider of the content for permission to reproduce.